Phibro Animal Health Corporation (PAHC)

Currency in USD
37.39
-0.44(-1.16%)
Closed·
37.390.00(0.00%)
·
PAHC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
37.0638.14
52 wk Range
16.1646.42
Key Statistics
Prev. Close
37.83
Open
37.74
Day's Range
37.06-38.14
52 wk Range
16.16-46.42
Volume
224.63K
Average Volume (3m)
293.42K
1-Year Change
72.78%
Book Value / Share
7.69
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAHC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
43.00
Upside
+15.00%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings upwards for the upcoming period
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Phibro Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Employees
2475

Phibro Animal Health Corporation Earnings Call Summary for Q1/2026

  • Phibro Animal Health reported Q1 FY2026 EPS of $0.73, exceeding forecasts by 21.67%, with revenue of $363.9 million, driving a 6.03% stock surge in premarket trading.
  • The animal health segment delivered exceptional performance with a 55% sales increase and 85% growth in adjusted EBITDA, positioning the company strongly against competitors.
  • Financial highlights include a 40% YoY revenue increase, 108% EPS growth, and 102% rise in adjusted EBITDA to $31.2 million.
  • Management provided bullish FY2026 guidance, projecting 10-14% net sales growth to $1,425-1,475 million and 25-30% adjusted EBITDA growth.
  • Strategic focus on dental health was emphasized as 'an unmet need within the vet and dog market,' with executives highlighting protein's increasing importance.
Last Updated: 06/11/2025, 16:00
Read Full Transcript

Compare PAHC to Peers and Sector

Metrics to compare
PAHC
Peers
Sector
Relationship
P/E Ratio
22.3x7.8x−0.6x
PEG Ratio
0.08−0.020.00
Price/Book
4.9x2.3x2.6x
Price / LTM Sales
1.1x2.5x3.2x
Upside (Analyst Target)
20.4%18.4%41.8%
Fair Value Upside
Unlock27.2%5.1%Unlock

Analyst Ratings

1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 43.00
(+15.00% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BofA Securities
Sell32.00-14.42%27.00Maintain06/11/2025
BNP Paribas Exane
Hold37.00-1.04%24.00Maintain04/09/2025
Morgan Stanley
Hold34.00-9.07%26.00Maintain29/08/2025
JPMorgan
Buy35.00-6.39%25.00Upgrade07/07/2025
Morgan Stanley
Hold26.00-30.46%21.00Maintain25/06/2025

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.67%
Dividend Yield
1.28%
Industry Median 2.50%
Annualised payout
0.48
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.73 / 0.60
Revenue / Forecast
363.90M / 345.44M
EPS Revisions
Last 90 days

Phibro (PAHC) Income Statement & Profits

People Also Watch

32.84
WAY
-0.21%
13.19
MG
+1.23%

FAQ

What Is the Phibro (PAHC) Share Price Today?

The live Phibro share price today is 37.39

What Stock Exchange Does Phibro (PAHC) Trade On?

Phibro is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Phibro?

The stock symbol (also called a 'ticker') for Phibro is "PAHC."

Does Phibro Pay Dividends? What’s The Current PAHC Dividend Yield?

Yes, PAHC Pays Dividends to its Shareholders. The current Phibro dividend yield is 1.28%.

What Is the Current Phibro Market Cap?

As of today, Phibro market capitalisation is 1.52B.

What Is Phibro's (PAHC) Earnings Per Share (TTM)?

The Phibro EPS is currently 1.67 (Trailing Twelve Months).

When Is the Next Phibro Earnings Date?

Phibro's next earnings report will be released on 11 Feb 2026.

Is PAHC a Buy or Sell From a Technical Analyst Perspective?

Based on today's Phibro moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Phibro Stock Split?

Phibro has split 0 times. (See the PAHC stock split history page for full effective split date and price information.)

How Many Employees Does Phibro Have?

Phibro has 2475 employees.

What is the current trading status of Phibro (PAHC)?

As of 24 Dec 2025, Phibro (PAHC) is trading at a price of 37.39, with a previous close of 37.83. The stock has fluctuated within a day range of 37.06 to 38.14, while its 52-week range spans from 16.16 to 46.42.

What Is Phibro (PAHC) Price Target According to Analysts?

The average 12-month price target for Phibro is USD43, with a high estimate of USD50 and a low estimate of USD32. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +15.00% Upside potential.

What Is the PAHC Premarket Price?

PAHC's last pre-market stock price is 39.51. The pre-market share volume is 1,000.00, and the stock has decreased by 1.68, or 4.44%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.